1 |
E.A. Klausner, S. Eyal, E. Lavy, M. Friedman and A. Hoffmana, Novel levodopa gastroretentive dosage form: invivo evaluation in dogs, J.Control. Release, 88, 117–126 (2003).
DOI
ScienceOn
|
2 |
L. Meka, B. Kesavan, K.M. Chinnala, V. Vobalaboina, and M.R. Yamsanil, Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: In vitro evaluation, AAPS PharmSciTech, 9(2), 612-618 (2008).
DOI
ScienceOn
|
3 |
M. Oth, M. Franz, J. Timmermans and A. Moes, The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9, 298-302 (1992)
DOI
ScienceOn
|
4 |
T. Gordi, E. Hou, S. Kasichayanula and B. Berner, Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive?extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, tree-way crossover, exploratory study in healthy subjects, Clinical Therapeutics, 30(5), 909-916 (2008).
DOI
ScienceOn
|
5 |
A.A. Deshpande, C.T. Rhodes, N.H. Shah and A.W. Malick, Controlled-release drug delivery systems for prolonged gastric residence, Drug Dev. Ind. Pharm., 22(6), 531-539 (1996).
DOI
ScienceOn
|
6 |
A. Streuble, J. Siepmann and R. Bodmeier, Gastroretentive drug delivery systems, Expert Opin. Drug Deliv., 3(2), 217- 233 (2006)
DOI
ScienceOn
|
7 |
Y.D. Tang, S.S. Venkatraman, F.Y.C. Boey and L.W. Wang, Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form, J. Pharmaceutics, 336, 159- 165 (2007).
DOI
ScienceOn
|
8 |
S. Frances, T.F. John, H.C. John, G.M. Luigi, L.S. Harbrans and S. Anne-marie, The use of citric acid to prolong the in vivo gastro retention of floating dosage form in the fasted state, Int. J. Pharmaceutics, 308, 8-13 (2006).
DOI
ScienceOn
|
9 |
H.Y. Cho, H.A. Kang, E.J. Park, S.W. Oh, J.D. Moon and Y.B. Lee, Bioequivalence of Kuhnil Gabapentin capsule 300 mg to Neurontin capsule 300 mg (gabapentin 300mg), J. Kor. Pharm. Sci., 35(3), 193-199 (2005).
과학기술학회마을
DOI
ScienceOn
|
10 |
A. Amin, T. Shah, D. Parikh and M Shah, Progress in swellable & low density excipients for prolonged gastric retention, Drug Delivery Tech., (Feb), 22-26 (2008).
|
11 |
T. Gordi, V. Cowles, Y.K. Chiang and E. Hou, Gabapentin pharmacokinetics after the administration of a gastric retentive formulation in postmenopausal women with hot flashes, Abstracts No. 1839, AAPS Annual Meeting, (2008).
|
12 |
V. Cowles, G. Gusler, R. Gu, J. Louie-Helm, E. Hou and B. Berner, Dose Proportionality of Gabapentin Gastric Retentive Extended-Release Tablets in Beagle Dog, Abstracts No. 2109, AAPS Annual Meeting, (2006).
|
13 |
M. Chavanpatil, P. Jain, S. Chaudhari, R. Shear and P. Vavia, Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation, Int. J. Pharm. 304, 178-184 (2005).
DOI
ScienceOn
|
14 |
B.N. Singh and H.N. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Release, 63, 235-259 (2000).
DOI
ScienceOn
|
15 |
S.S. Ahmed and J.W. Ayres, Bioavailability of riboflavin from a gastric retention formulation, Int. J. Pharmaceutics, 330, 146-154 (2007).
DOI
ScienceOn
|
16 |
E.A. Klausner, E. Lavy, M. Friedman, A. Hoffman, Expandable gastroretentive dosage form, J. Control. Release, 90, 142-162 (2003).
DOI
ScienceOn
|